Here's a 200 Bagger plan involving TAJ and VVN. When you look at this plan consider the market caps involved and you will see it really could happen. http://www.stockhouse.com/bullboards/messagedetail.aspx?s=VVN&t=LIST&m=32514891&l=0&pd=0&r=0

Guys and gals, this one is worth checking out. v.TAJ Drilling with results due mid May (3 wks). Their neighbour that surrounds their property has been bought out by an Australian company for $188 million. An open pit mine will be developed by this Australian company. If TAJ comes up with good results, they will in all likely hood be scooped up by this Australian company unless results are so good ...

Guys you really should check out this great spec that is setting up in Guyana. v.TAJ Drilling with results due mid May (3 wks). Their neighbour that surrounds their property has been bought out by an Australian company for $188 million. An open pit mine will be developed by this Australian company. If TAJ comes up with good results, they will in all likely hood be scooped up by this Australian co ...

With only a month left until Nupathe's PDUFA date of January 17, expect to see PATH move higher. Outstanding opportunity for this tiny cap biotech to corner a massive slice of the migraine headache market. Opportunities like this one don't come by every day or every month for that matter. Just watch this baby go. http://www.stockhouse.com/blogs/viewdetailedpost.aspx?p=156433

Migraine headaches have to be up there on the list of common medical ailments. Nupathe has a patented patch delivery system that will transdermally deliver Sumatriptan to migrane sufferers on FDA approval this coming January. With 31 million migrane sufferers in the U.S. and 8 million of them experiencing nausea in over 50% of their migranes, Nupathe has an excellent opportunity to corner a massi ...